首页/数据集/Tumor characteristics and response to sorafenib for individual patients.

Tumor characteristics and response to sorafenib for individual patients.

NIAID Data Ecosystem2026-03-06 收录

数据链接：

https://figshare.com/articles/dataset/_Tumor_characteristics_and_response_to_sorafenib_for_individual_patients_/479951 数据链接链接失效反馈

官方服务：

资源简介：

MSPCR: mutant specific PCR; h∶high; na: not available; AJCC: American Joint Committee on Cancer.

应用场景：

创建时间：

2010-12-29

肿瘤突变特征

逆转录转座子

Xeroderma Pigmentosum variant (XP-V) is an autosomal recessive disease with an increased risk to develop cutaneous neoplasms in sunlight exposed regions. These cells are deficient in the translesion s

NIAID Data Ecosystem40

DataSheet_2_Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC.docx

NSCLC非小细胞肺癌

肿瘤突变特征

BackgroundImmunotherapy has become increasingly important in the perioperative period of non-small-cell lung cancer (NSCLC). In this study, we intended to develop a mutation-based model to predict the

NIAID Data Ecosystem40

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort

头颈部鳞状细胞癌基因

肿瘤突变特征

While whole-exome DNA sequencing is the most common technology to study genetic variants in known exonic regions, RNA-seq is a cheaper, viable alternative to study expressed mutations in tumors. In th

NIAID Data Ecosystem30

Mutational signatures and increased retrotransposon insertions in Xeroderma Pigmentosum variant skin tumors

肿瘤突变特征

逆转录转座子

NIAID Data Ecosystem40

Additional file 1 of Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden

癌症基因组数据

肿瘤突变特征

Additional file 1. Supplementary data from mutational analysis (MutSigCV, Intogen, Intogen Pathways and COSMIC mutational signatures).

Figshare2021-07-14 更新30